ARS Pharmaceuticals, Inc. (SPRY) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of a loss of $0.04 per share. This compares to loss of $0.07 per share a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback